Crocs (NASDAQ:CROX) Stock Price Breaks Above Two Hundred Day Moving Average – Time to Sell?

Crocs, Inc. (NASDAQ:CROX)’s share price passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $114.35 and traded as high as $123.52. Crocs shares last traded at $117.4330, with a volume of 1,036,754 shares traded.

Analyst Upgrades and Downgrades

Several research firms have commented on CROX. Piper Sandler restated an “overweight” rating on shares of Crocs in a research note on Friday, July 31st. The Goldman Sachs Group restated a “sell” rating and set a $95.00 price objective on shares of Crocs in a research note on Friday, July 31st. Royal Bank Of Canada began coverage on Crocs in a research report on Monday, June 8th. They issued an “overweight” rating on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Crocs in a report on Monday, June 8th. They set a “buy” rating on the stock. Finally, Weiss Ratings lowered shares of Crocs from a “hold (c+)” rating to a “hold (c)” rating in a report on Tuesday, September 8th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Crocs presently has a consensus rating of “Moderate Buy” and an average target price of $139.10.

Crocs Trading Down 0.9%

The company has a market cap of $5.67 billion, a P/E ratio of 10.21, a PEG ratio of 0.98 and a beta of 1.56. The firm’s 50 day moving average is $124.44 and its two-hundred day moving average is $114.64. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.94.

Crocs (NASDAQ:CROX) last issued its quarterly earnings results on Thursday, July 30th. The textile maker reported $4.55 earnings per share for the quarter, beating the consensus estimate of $4.35 by $0.20. Crocs had a return on equity of 47.75% and a net margin of 14.64%.The company had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the firm posted ($8.82) earnings per share. The business’s quarterly revenue was up 2.6% on a year-over-year basis. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. As a group, equities research analysts anticipate that Crocs, Inc. will post 13.95 EPS for the current year.

Insider Transactions at Crocs

In related news, CEO Andrew Rees sold 19,072 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $138.91, for a total transaction of $2,649,291.52. Following the sale, the chief executive officer owned 713,293 shares in the company, valued at $99,083,530.63. This represents a 2.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Beth Kaplan purchased 885 shares of the company’s stock in a transaction on Tuesday, September 15th. The stock was acquired at an average cost of $112.12 per share, for a total transaction of $99,226.20. Following the completion of the purchase, the director owned 15,259 shares of the company’s stock, valued at approximately $1,710,839.08. This trade represents a 6.16% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 3.10% of the company’s stock.

Institutional Investors Weigh In On Crocs

Several hedge funds and other institutional investors have recently bought and sold shares of CROX. BlackRock Inc. bought a new position in Crocs in the second quarter worth approximately $561,223,000. Patient Capital Management LLC bought a new position in shares of Crocs in the 2nd quarter worth $96,443,000. Norges Bank bought a new position in shares of Crocs in the 4th quarter worth $67,545,000. Himalaya Capital Management LLC acquired a new stake in Crocs in the 4th quarter valued at $53,720,000. Finally, Contrarius Group Holdings Ltd increased its stake in Crocs by 324.1% during the 4th quarter. Contrarius Group Holdings Ltd now owns 475,011 shares of the textile maker’s stock valued at $40,623,000 after purchasing an additional 363,010 shares in the last quarter. 93.44% of the stock is owned by institutional investors.

About Crocs

Crocs, Inc is a global footwear company best known for its molded clogs made from Croslite, a proprietary material designed to provide lightweight comfort and water resistance. The company’s product portfolio also includes sandals, slides, boots, sneakers and other casual footwear, along with Jibbitz charms and accessories that allow consumers to personalize Crocs shoes.

Founded in 2002, Crocs sells its products through company-operated and partner retail stores, e-commerce websites, wholesale partners and third-party digital marketplaces.